Expression of Wild-Type Rp1 Protein in Rp1 Knock-in Mice Rescues the Retinal Degeneration Phenotype

Qin Liu(Massachusetts Eye and Ear Infirmary), Eric A. Pierce(Broad Institute), L. Ingeborgh van den Born(Rotterdam Eye Hospital), Anneke I. den Hollander(Radboud University Nijmegen), Rob W.J. Collin(Radboud University Nijmegen), Frans P.M. Cremers(Radboud University Nijmegen)
PLoS ONE
August 21, 2012
10.1371/journal.pone.0043251
Cited by 29

Related Papers

Safety and Efficacy of Gene Transfer for Leber's Congenital Amaurosis
|New England Journal of Medicine|2008|2.1k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.
|Proceedings of the National Academy of Sciences|1995|1k
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial
|The Lancet|2009|864
Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration
|Molecular Therapy|2009|551